EUR 24.5
(0.41%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.34 Billion | 4.07 Billion | 3.37 Billion | 2.63 Billion | 2.36 Billion |
Cost of Revenue | 2.32 Billion | 2.07 Billion | 1.72 Billion | 1.32 Billion | 1.11 Billion |
Gross Profit | 2.02 Billion | 1.99 Billion | 1.65 Billion | 1.3 Billion | 1.25 Billion |
Operating Expenses | 1.8 Billion | 1.73 Billion | 1.38 Billion | 1.21 Billion | 1.18 Billion |
Selling, General and Administrative Expenses | 564.3 Million | 542.55 Million | 496.58 Million | 458.49 Million | 469.63 Million |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 1.23 Billion | 1.19 Billion | - | - | - |
Cost and Expenses | 4.12 Billion | 3.8 Billion | 3.11 Billion | 2.53 Billion | 2.29 Billion |
Operating Income | 220.8 Million | 265.06 Million | 220.21 Million | 151.34 Million | 105.19 Million |
Interest Expense | - | - | - | - | - |
Income Tax Expense | 69.8 Million | 55.86 Million | 68.14 Million | 34.86 Million | 22.25 Million |
Earnings before Tax | 307.5 Million | 299.52 Million | 287.23 Million | 115.19 Million | 84.68 Million |
Net Income | 240.8 Million | 243.64 Million | 218.71 Million | 80.18 Million | 62.88 Million |
Earnings Per Share Basic | 3.23 | 3.29 | 2.95 | 1.08 | 0.85 |
Earnings Per Share Diluted | 3.23 | 3.29 | 2.95 | 1.08 | 0.85 |
Weighted Average Shares Outstanding | 73.82 Million | 74.01 Million | 74.09 Million | 74.15 Million | 74.39 Million |
Weighted Average Shares Outstanding (Diluted) | 73.82 Million | 74.01 Million | 74.09 Million | 74.15 Million | 74.39 Million |
Gross Margin | 0.47 | 0.49 | 0.49 | 0.50 | 0.53 |
EBIT Margin | 0.07 | 0.10 | 0.09 | 0.09 | 0.08 |
Profit Margin | 0.06 | 0.06 | 0.06 | 0.03 | 0.03 |
EBITDA | 323.22 Million | 396.4 Million | 317.83 Million | 233.34 Million | 185.77 Million |
Earnings Before Tax Margin | 0.05 | 0.07 | 0.07 | 0.06 | 0.04 |
Breakdown | 2023 Q4 | 2023 Q3 | 2022 FY | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Revenue | 1.03 Billion | 1.03 Billion | 3.91 Billion | 1.08 Billion | 1.08 Billion | 873.83 Million |
Cost of Revenue | 549.85 Million | 549.85 Million | 2.07 Billion | 582.87 Million | 582.87 Million | 454.03 Million |
Gross Profit | 486.2 Million | 486.2 Million | 1.83 Billion | 499.04 Million | 499.04 Million | 419.8 Million |
Operating Expenses | 447.59 Million | 447.59 Million | 1.58 Billion | 404.18 Million | 404.18 Million | 386.3 Million |
Selling, General and Administrative Expenses | 139.45 Million | 139.45 Million | - | 137.33 Million | 137.33 Million | 133.93 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 997.44 Million | 997.44 Million | 3.65 Billion | 987.06 Million | 987.06 Million | 840.33 Million |
Operating Income | 45.2 Million | 45.2 Million | 293.88 Million | 104.16 Million | 104.16 Million | 42.77 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 10.85 Million | 10.85 Million | 55.86 Million | 22.11 Million | 22.11 Million | 5.82 Million |
Earnings before Tax | 58.75 Million | 58.75 Million | 299.52 Million | 106.82 Million | 106.82 Million | 42.94 Million |
Net Income | 48.2 Million | 48.2 Million | 243.64 Million | 84.76 Million | 84.76 Million | 37.05 Million |
Earnings Per Share Basic | 0.65 | 0.65 | - | 1.15 | 1.15 | 0.50 |
Earnings Per Share Diluted | 0.65 | 0.65 | - | 1.15 | 1.15 | 0.50 |
Weighted Average Shares Outstanding | 73.82 Million | 73.82 Million | 74.01 Million | 73.82 Million | 73.82 Million | 74.21 Million |
Weighted Average Shares Outstanding (Diluted) | 73.82 Million | 73.82 Million | 74.01 Million | 73.82 Million | 73.82 Million | 74.21 Million |
Gross Margin | 0.47 | 0.47 | 0.47 | 0.46 | 0.46 | 0.48 |
EBIT Margin | 0.07 | 0.07 | - | 0.12 | 0.12 | 0.08 |
Profit Margin | 0.05 | 0.05 | 0.06 | 0.08 | 0.08 | 0.04 |
EBITDA | 70.83 Million | 70.83 Million | - | 131.4 Million | 131.4 Million | 66.8 Million |
Earnings Before Tax Margin | 0.04 | 0.04 | 0.08 | 0.10 | 0.10 | 0.05 |
PLSR
002527
BMOB3
CRWOF
REGENCERAM
002947